Conference Paper: A randomized trial of telbivudine (LDT) vs. adefovir for HBeAg-positive chronic hepatitis B: Results of the primary week 24 analysis

File Download Links for fulltext
(May Require Subscription)
  • Find via
Supplementary

  • Basic View
  • Metadata View
  • XML View
TitleA randomized trial of telbivudine (LDT) vs. adefovir for HBeAg-positive chronic hepatitis B: Results of the primary week 24 analysis
AuthorsChan, HLY
Lai, CL
Cho, M
Heathcote, J
Moon, Y-M
Chao, Y-C
Myers, R
Minuk, G
Marcellin, P
Jeffers, L
Sievert, W
Kaiser, R
Chao, G
Brown, N
Issue Date2006
PublisherElsevier BV. The Journal's web site is located at http://www.elsevier.com/locate/jhep
CitationJournal of Hepatology, v. 44 n. Suppl 2, p. S24-25 [How to Cite?]
ISSN0168-8278
2011 Impact Factor: 9.264
2011 SCImago Journal Rankings: 0.765
DC Field
Value
dc.contributor.authorChan, HLY
dc.contributor.authorLai, CL
dc.contributor.authorCho, M
dc.contributor.authorHeathcote, J
dc.contributor.authorMoon, Y-M
dc.contributor.authorChao, Y-C
dc.contributor.authorMyers, R
dc.contributor.authorMinuk, G
dc.contributor.authorMarcellin, P
dc.contributor.authorJeffers, L
dc.contributor.authorSievert, W
dc.contributor.authorKaiser, R
dc.contributor.authorChao, G
dc.contributor.authorBrown, N
dc.date.accessioned2010-09-25T20:36:25Z
dc.date.available2010-09-25T20:36:25Z
dc.date.issued2006
dc.identifier.citationJournal of Hepatology, v. 44 n. Suppl 2, p. S24-25 [How to Cite?]
dc.identifier.epage25
dc.identifier.hkuros122310
dc.identifier.issn0168-8278
2011 Impact Factor: 9.264
2011 SCImago Journal Rankings: 0.765
dc.identifier.issueSuppl 2
dc.identifier.openurl
dc.identifier.spage24
dc.identifier.urihttp://hdl.handle.net/10722/102581
dc.identifier.volume, v. 44 n. Suppl 2
dc.languageeng
dc.publisherElsevier BV. The Journal's web site is located at http://www.elsevier.com/locate/jhep
dc.relation.ispartofJournal of Hepatology
dc.rightsJournal of Hepatology. Copyright © Elsevier BV.
dc.titleA randomized trial of telbivudine (LDT) vs. adefovir for HBeAg-positive chronic hepatitis B: Results of the primary week 24 analysis
dc.typeConference_Paper